by Rebecca McGreal. / Vita. / Thesis (Ph.D.)--Florida Atlantic University, 2012. / Includes bibliography. / Electronic reproduction. Boca Raton, Fla., 2012. Mode of access: World Wide Web. / The central premise of this dissertation is that the small heat shock protein (sHSP), (Sa(BB-crystallin is essential for lens and retinal pigmented epithelial (RPE) cell function and oxidative stress defense. To date, the mechanism by which it confers protection is not known. We hypothesize that these functions could occur through its ability to protect mitochondrial function in lens and RPE cells. To test this hypothesis, we examined the expression of (Sa(BB-crystallin/sHSP in lens and RPE cells, we observed its localization in the cells, we examined translocation to the mitochondria in these cells upon oxidative stress treatment, we determined its ability to form complexes with and protect cytochrome c (cyt c) against damage, and we observed its ability to preserve mitochondrial function under oxidative stress conditions in lens and RPE cells. In addition to these studies, we examined the effect of mutations of (Sa(BB-crystallin/sHSP on its cellular localization and translocation patterns under oxidative stress, its in vivo and in vitro chaperone activity, and its ability to protect cyt c against oxidation. Our data demonstrated that (Sa(BB-crystallin/sHSP is expressed at high levels in the mitochondria of lens and RPE cells and specifically translocates to the mitochondria under oxidative stress conditions. We demonstrate that (Sa(BB-crystallin/sHSP complexes with cyt c and protects it against oxidative inactivation. Finally, we demonstrate that (Sa(BB-crystallin/sHSP directly protects mitochondria against oxidative inactivation in lens and RPE cells. Since oxidative stress is a key component of lens cataract formation and age-related macular degeneration (AMD), these data provide a new paradigm for understanding the etiology of these diseases.

Objetivo: Avaliar a função visual de pacientes submetidos a transplante lamelar anterior profundo (DALK) utilizando a dissecção com tunelizador manual e fio. Métodos: Foram incluídos 33 pacientes com ceratocone que apresentavam BCVA <= 0,60 LogMar, miopia e astigmatismo entre 8,00 e 10,00D, K central médio > 53,00D, ausência de cicatrizes, espessura corneana mínima entre 300 e 400 um. Foi feita avaliação oftalmológica completa no pré e no pós-operatório de 6 a 8 meses. Estas avaliações foram complementadas com exame topográfico da córnea, microscopia especular para avaliação da densidade das células endoteliais corneanas, aberrometria corneana e exame de tomografia de coerência óptica do segmento anterior. As variáveis BCVA, UCBA e os valores totais das aberrações corneanas de alta ordem foram correlacionadas com a espessura do leito estromal residual. Resultados: Os pacientes submetidos à DALK apresentaram BCVA de 0,68 ± 0,27 LogMar o que representa BCVA superior a 20/40 em 60% da amostra analisada. Não foram observadas micro ou macroperfurações. Houve diminuição na contagem endotelial de 2702,87 ± 548,87 células por mm2 para 2282,10 ± 525,66 células por mm2 . A dissecção do estroma profundo com o fio facilitou a remoção de tecido estromal posterior, fato corroborado com o achado de que o leito residual estromal aferido foi de 49,18 ± 18,36 ?m na região central e foi inferior a 80 ?m em grande parte dos pacientes estudados. No que se refere à regularidade da dissecção, observou-se tendência a valores mais elevados de espessura residual na periferia (60,09 ± 17,70 ?m). Não houve correlação da BCVA, UCVA e do total de aberrações de alta ordem da córnea com a espessura do leito estromal residual. Conclusão: A apreciação dos resultados desse estudo mostrou que com a técnica utilizada para realização de DALK em portadores de ceratocone obteve-se resultados topográficos e funcionais semelhantes a outras técnicas consagradas pela literatura. A facilidade na dissecção do estroma profundo, a regularidade da dissecção e a presença de baixíssimo índice de conversão para transplantes penetrantes são encorajadores / Objective: Evaluate the visual function of patients undergoing deep anterior lamellar keratoplasty (DALK) using a manual spatula and a wire dissection. Methods: Thirty three keratoconus patients were included, meeting the following inclusion criteria: BCVA logMAR <=0,60, myopia and astigmatism between 8.00 and 10,00D, K central average > 53.00D, no corneal scars and minimal corneal thickness between 300 and 400 um. Complete ocular evaluation was performed preoperatively and postoperatively in 6-8 months. These assessments were supplemented by topographical survey of the cornea, specular microscopy to evaluate the density of corneal endothelial cells, corneal wavefront analysis and examination of optical coherence tomography of the anterior segment (Visante). The BCVA variables, UCVA and the total amounts of corneal higher-order aberrations were correlated with the the residual stromal bed thickness. Results: Patients that undergone to DALK with the described technique presented a BCVA of 0.68 ± 0.27 logMAR which represents a BCVA of more than 20/40 at 60% of the analyzed sample. There were no micro or macroperforations. We observed a small decrease in the endothelial cell count from 2702.87 ± 548.87 cells per mm2 to 2282.10 ± 525.66 cells per mm2. The dissection of the deep stroma with a wire facilitated the posterior stromal tissue removal, thus the measured stromal bed thickness was 49.18 ± 18.36 ?m in the central region and less than 80 ?m in the majority of the studied patients. As regards the dissection regularity, we showed a tendency to higher values of residual thickness at the periphery (60.09 ± 17.70 ?m). There was no correlation of the BCVA, UCVA and total corneal higher-order aberrations with the residual stromal bed thickness. Conclusion: The assessment of the study data showed that the described technique achieved a topographical and functional result similar to other techniques consecrated by literature. The shallow learning curve, the ease to perform the dissection of the deep stroma, the postoperative stromal regularity and the presence of very low conversion rate for penetrating keratoplasty are encouraging

葡萄膜炎是一組複雜的眼內炎性疾病，可導致嚴重的視力損害，約占世界範圍內工作年齡人群組致盲眼病的10%。孫然治療上已取得一定的進步，但找尋安全有效的治療方式仍是一個臨床難題。基於解剖學分類，葡萄膜炎分為前葡萄膜炎、中葡萄膜炎、后葡萄膜炎和全葡萄膜炎。其中，前葡萄膜炎 (AU) 為最常見的臨床形式。此外，基於病因學葡萄膜炎也可被歸類為感染性和非感染性兩大亞型。作為一種炎症性疾病，已有研究表明許多內源性的免疫機制及遺傳因素參與葡萄膜炎的形成。 / 基於對葡萄膜炎疾病進程的深入瞭解，兩條主要潛在的致病通路：T細胞反應途徑和補體系統顯示在分子水平與疾病密切相關。本研究涉及參與上述兩通路的諸多因子，旨在調查葡萄膜炎的遺傳易感性，揭示潛在致病機理，以及發現新的臨床診斷標記物。 / 本研究共納入501名參與者，包括98名AU患者，95名非感染性中後葡萄膜炎 (NIPU) 患者，病例收集自香港眼科醫院及威爾斯親王醫院。此外，308名年齡50歲以上，排除了主要眼科疾患及系統性免疫疾病的健康人被招募為對照組。全面詳細記錄病人資料及臨床信息。進一步剖析葡萄膜炎疾病特點及補體通路參與程度，深入研究補體基因的累加效應及相互作用，以期發現臨床標記物。最後，採用基因型表型相關性分析，探索其與疾病嚴重程度和進展的關係。 / 研究1：系統性綜述在葡萄膜炎基因學研究上的最新發現，研究表明多種基因與葡萄膜炎疾病相關，所涉基因包括白介素、趨化因子、腫瘤壞死因子，以及參與補體和氧化途徑的相關基因。我們廣泛調查了葡萄膜炎的遺傳易感性。基因多態性選擇基於疾病的免疫及炎性特徵。（1）Interleukin與CFH基因，分別參與T細胞反應及補體通路。（2）CFB，CFH的拮抗因子，共同參與了補體旁路的調控。（3）調查C1INH(SERPING1) 因子，闡明補體經典通路在葡萄膜炎形成中的作用。（4）C3和C5基因，分別作為補體系統的“中心“因子及下游調控因子，其與葡萄膜炎的相關性被深入調查。 / 研究 2：首先探索性地調查免疫相關基因的單核苷酸多態性，包括CFH，KIAA1109 與 IL27 基因，我們的結果顯示 CFH 基因多態性 (rs800292，rs1065489) 與前葡萄膜炎顯著相關。更重要的是，CFH-rs1065489 TT基因型被確認為臨床標記物，此基因型攜帶者表現更高的葡萄膜炎復發頻率。此外，易感基因與HLA-B27的交互作用以及性別敏感性差異亦被發現。本研究的第二部份，此三個候選基因在另一個葡萄膜炎亞組NIPU中被進一步調查，CFH基因多態性 (rs800292，rs1065489) 與NIPU相關。KIAA1109-rs4505848也被發現與白塞氏病密切相關。此外，該基因多態性亦表現性別差異，較之對照組，顯性基因型頻率在男性NIPU組表現較高(GG/AG vs. AA)。 / 研究 3：CFB，作為CFH的拮抗因子，共同參與補體旁路的調控，其編碼基因被進一步調查。在AU研究中，位於C2/CFB區域的rs1048709被發現與其密切相關，該遺傳敏感性受HLA-B27影響。此外，我們還發現一個單體型 (AATA) 以及CFH與CFB的疊加效應均可導致AU風險度增高。同時，攜帶rs1048709(AG) 基因型患者傾向于更高程度的前房細胞數及KP比例。在NIPU研究中，類似的與CFB基因上的不同易感位點rs4151657相關性亦被檢測到。 / 研究 4, 5, 6: 在隨後的研究中，參與補體通路的其他三個候選基因 (SERPING1，C3和C5) 被進一步評估，儘管多種深入的分析方法被應用，但均未顯示出與疾病明確的相關性。 / 綜上，我們的結果首次揭示補體系統及其分子因素在葡萄膜炎進程中起著至關重要的作用。參與補體旁路調控的細胞因子 CFH 與 CFB，被確認為疾病風險因素。此外，分別參與補體經典通路或下游調控體系的其他三個候選基因 SERPING1(C1INH)，C3 和 C5， 以及參與T細胞反應通路的IL2_21區域和IL27基因在葡萄膜炎的發生發展中所起作用有限。因此，將來對於葡萄膜炎基因學及免疫學的研究應著眼于補體系統及其旁路途徑。 / Uveitis is a group of heterogeneous ocular inflammatory diseases with complex phenotypes, which causes substantial visual impairment and accounts for about 10% of blindness worldwide among the working age group. Despite considerable progress in treatment, safe and effective management is still a clinical challenge. Uveitis can be anatomically classified as anterior, intermediate, posterior, and panuveitis, anterior uveitis (AU) is the most common form. Based on etiology, uveitis can be also categorized as infectious and noninfectious subtypes. Uveitis is generally accepted as an inflammatory condition and regulated by various endogenous immunological mechanisms. Moreover, uveitis can occur in individuals with genetic predisposition coupled with environmental factors. / Based on our understanding of the critical checkpoints in the uveitis process, two major pathways, T-cell response and complement system, appear to be most related to uveitis in the molecular level. We therefore target on several molecular factors involved in the two major pathways to evaluate the genetic impact on susceptibility to uveitis, reveal potential disease mechanisms, and discover diagnostic markers. / We recruited a total of 501 unrelated Chinese individuals at the Hong Kong Eye Hospital and the Prince of Wales Hospital in Hong Kong, including 98 AU patients, 95 patients with noninfectious intermediate and posterior uveitis (NIPU), and 308 control subjects aged ≥ 50 years without major eye diseases or any systemic immune-related disorders. Clinical information and demographic conditions of the patients were documented. We moved on to depict the disease profile and estimate the contribution of each complement activation pathway in uveitis process. We also conducted interaction analysis among the complement factor genes to reveal the putative clinical markers for uveitis. Genotype-phenotype correlations were performed to explore their relationships with the disease severity and progression. / Study 1: In a systemic review to explore recent genetic findings in uveitis susceptibility, we found several genes persistently associated with uveitis and involved in various pathways. They are genes expressing interleukin, chemokine, tumor necrosis factor, and genes involved in complement and oxidation pathways. Genetic polymorphisms were selected based on the immunological and inflammatory properties of uveitis. (1) Interleukin and CFH genes, involving in the T-cell response and complement system respectively. (2) CFB, as a competitor of CFH, involved in the alternative pathway of complement cascade together. (3) Investigation of C1INH (SERPING1) in uveitis, with a view to elucidating the involvement of the classic pathway of complement cascade in uveitis development. (4) Evaluation of C3 and C5 genes in uveitis, due to their respective role of center component and downstream factor in the complement cascade. / Study 2: Genetic variations in the CFH, KIAA1109 and IL27 genes were examined. Our results showed an association between AU and CFH polymorphisms (rs800292 and rs1065489). The frequency of the CFH-rs800292 184G allele and GG homozygosity was higher in female patients than in controls. CFH-rs1065489 TT genotype was identified as a clinical marker associated with higher uveitis recurrence frequency. Interactions with HLA-B27 status in AU patients and different gender susceptibility were observed. In the second part of this study, these three candidate genes were examined in the other uveitic entity, NIPU, in our study cohort. CFH gene polymorphisms (rs1065489 and rs800292) were associated with NIPU patients. Specific association between KIAA1109-rs4505848 polymorphism and Behçet’s disease was identified. There was also gender specific genetic difference. The dominant genotype of KIAA1109-rs4505848 in male NIPU patients was significantly more frequent than in male controls (GG/AG vs. AA). / Study 3: CFB, a competitor of CFH and participated in the same complement alternative pathway, was investigated. SNP rs1048709 in the C2/CFB region was associated with AU, and this genetic influence was affected by HLA-B27 status. Furthermore, one haplotype block across CFB (AATA) significantly predisposed AU with an increased risk of 1.97 (95% CI: 1.41-2.76; Pcorr=0.0005). Joint effects of CFB-rs1048709 with (CFH-rs800292 and CFH-rs1065489) were identified to be at a risk of 7.48 and 7.0 respectively. In addition, patients carrying rs1048709 (AG) were predicted to develop a higher degree of anterior chamber cells and higher proportion of keratic precipitate (KP) during AU course. For NIPU, association with CFB was detected for a different SNP, rs4151657, in female patients only. / Studies 4, 5, and 6: Three candidate genes (SERPING1, C3 and C5) across the complement cascade were orderly evaluated in the whole study cohort of AU, NIPU and controls. They did not show any significant associations with both two uveitis entities, although multiple in-depth analyses have been performed. / Collectively, our results provide evidence for the involvement of the complement system in the disease pathogenesis of uveitis. CFH and CFB, involved in the complement alternative pathway, are identified as genetic risk factors for uveitis. Other complement pathway genes, SERPING1 (C1INH), C3 and C5, as well as IL2_21 region and IL27 involving in the T-cell response, confer either no or limited risk for the development of uveitis. Future genetic and immunologic investigations in uveitis should therefore be focused on the complement system and the alternative pathway. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Yang, Mingming. / Thesis (Ph.D.)--Chinese University of Hong Kong, 2013. / Includes bibliographical references (leaves 148-163). / Abstracts also in Chinese. / Title page --- p.i / Abstract --- p.iii / 摘要 --- p.vii / Acknowledgement --- p.x / Table of Contents --- p.xi / List of Tables --- p.xvi / List of Figures --- p.xx / Abbreviations --- p.xxi / Publications and Conference Presentation --- p.xxiv / Awards Received --- p.xxvii / Chapter Chapter 1 --- General Introduction --- p.1 / Chapter 1.1 --- Uveitis-one of the most challenging dilemmas in ophthalmology --- p.1 / Chapter 1.1.1 --- Classification of uveitis --- p.4 / Chapter 1.1.2 --- Clinical characteristics of uveitis --- p.5 / Chapter 1.1.3 --- Epidemiology of uveitis --- p.6 / Chapter 1.1.4 --- Etiology of uveitis --- p.9 / Chapter 1.1.5 --- Current management of uveitis and future perspectives --- p.11 / Chapter 1.2 --- The Descriptive Complexity of Uveitis --- p.13 / Chapter 1.3 --- Uveitis Genetics Research Strategies --- p.14 / Chapter 1.3.1 --- Candidate gene association study --- p.14 / Chapter 1.3.2 --- The identification of new genes --- p.15 / Chapter 1.4 --- Statistical Genetics for Uveitis --- p.16 / Chapter 1.4.1 --- Hardy-Weinberg equilibrium test --- p.16 / Chapter 1.4.2 --- Univariate analysis --- p.16 / Chapter 1.4.3 --- Linkage disequilibrium --- p.17 / Chapter 1.4.4 --- Haplotype analysis --- p.18 / Chapter 1.4.5 --- Multivariable analysis --- p.19 / Chapter Chapter 2 --- Objectives --- p.21 / Chapter Chapter 3 --- General Materials and Methods --- p.23 / Chapter 3.1 --- Overall Study Design --- p.23 / Chapter 3.2 --- Research Ethics --- p.23 / Chapter 3.3 --- Study Subjects Recruitment --- p.23 / Chapter 3.4 --- Demographic and Clinical Characteristics of Patients --- p.24 / Chapter 3.4.1 --- Anterior uveitis (AU) --- p.24 / Chapter 3.4.2 --- Non-infectious intermediate and posterior uveitis (NIPU) --- p.25 / Chapter 3.5 --- General Methods --- p.26 / Chapter 3.5.1 --- Total genomic DNA extraction in study subjects --- p.26 / Chapter 3.5.2 --- Taqman SNP genotyping --- p.27 / Chapter 3.5.3 --- Nested polymerase chain reaction (nPCR) --- p.27 / Chapter 3.6 --- Statistical Analysis --- p.28 / Chapter 3.6.1 --- Hardy-Weinberg equilibrium test --- p.28 / Chapter 3.6.2 --- Individual SNP association analysis --- p.28 / Chapter 3.6.3 --- Pairwise linkage disequilibrium and haplotype analysis --- p.30 / Chapter 3.6.4 --- Genotype-phenotype correlation analysis --- p.31 / Chapter 3.6.5 --- Gene-gene interaction analysis --- p.31 / Chapter Chapter 4 --- Investigation into Genetic Determinants of Uveitis --- p.32 / Chapter 4.1 --- A Critical Review on The Roles of Genetic Factors in Uveitis --- p.32 / Chapter 4.1.1 --- Human leukocyte antigens (HLA) --- p.33 / Chapter 4.1.2 --- Interleukin (IL) genes --- p.36 / Chapter 4.1.3 --- Chemokine and chemokine receptor genes --- p.37 / Chapter 4.1.4 --- Tumor necrosis factor (TNF) genes --- p.39 / Chapter 4.1.5 --- Other genes implicated in susceptibility to uveitis --- p.40 / Chapter 4.1.6 --- Complement system --- p.42 / Chapter 4.1.7 --- Conclusions and directions --- p.43 / Chapter 4.2 --- Interleukin and CFH Polymorphisms in Uveitis --- p.49 / Chapter 4.2.1 --- Introduction --- p.49 / Chapter 4.2.2 --- Study subjects --- p.50 / Chapter 4.2.3 --- SNP selection and genotyping --- p.50 / Chapter 4.2.4 --- Statistical analysis --- p.51 / Chapter 4.2.5 --- Association of interleukin and CFH polymorphisms with AU --- p.51 / Chapter 4.2.5.1 --- Association between SNPs and AU --- p.51 / Chapter 4.2.5.2 --- Association between SNPs and AU stratified by gender --- p.52 / Chapter 4.2.5.3 --- Association between SNPs and AU stratified by HLA-B27 status --- p.52 / Chapter 4.2.5.4 --- Genotype-phenotype correlation analysis --- p.53 / Chapter 4.2.6 --- Association of interleukin and CFH polymorphisms with NIPU --- p.53 / Chapter 4.2.6.1 --- Association between SNPs and NIPU --- p.53 / Chapter 4.2.6.2 --- Association between SNPs and NIPU stratified by subtypes --- p.54 / Chapter 4.2.6.3 --- Association between SNPs and NIPU stratified by gender --- p.54 / Chapter 4.2.7 --- Discussion --- p.55 / Chapter 4.2.7.1 --- Association of interleukin and CFH polymorphisms with AU --- p.55 / Chapter 4.2.7.2 --- Association of interleukin and CFH polymorphisms with NIPU --- p.58 / Chapter 4.3 --- C2/CFB Polymorphisms in Uveitis --- p.70 / Chapter 4.3.1 --- Introduction --- p.70 / Chapter 4.3.2 --- Study subjects --- p.70 / Chapter 4.3.3 --- SNP selection and genotyping --- p.70 / Chapter 4.3.4 --- Statistical analysis --- p.71 / Chapter 4.3.5 --- Association of C2/CFB polymorphisms with AU --- p.71 / Chapter 4.3.5.1 --- Association between SNPs and AU --- p.71 / Chapter 4.3.5.2 --- Association between SNPs and AU stratified by HLA-B27 status --- p.72 / Chapter 4.3.5.3 --- Linkage disequilibrium and haplotype association analysis --- p.73 / Chapter 4.3.5.4 --- Genotype-phenotype correlation analysis --- p.73 / Chapter 4.3.5.5 --- Joint-effect analysis between CFH and CFB in AU --- p.73 / Chapter 4.3.6 --- Association of C2/CFB polymorphisms with NIPU --- p.74 / Chapter 4.3.6.1 --- Association between SNPs and NIPU --- p.74 / Chapter 4.3.6.2 --- Association between SNPs and NIPU stratified by subtypes --- p.74 / Chapter 4.3.6.3 --- Association between SNPs and NIPU stratified by gender --- p.75 / Chapter 4.3.6.4 --- Linkage disequilibrium and haplotype association analysis --- p.75 / Chapter 4.3.7 --- Discussion --- p.75 / Chapter 4.3.7.1 --- Association of C2/CFB polymorphisms with AU --- p.75 / Chapter 4.3.7.2 --- Association of C2/CFB polymorphisms with NIPU --- p.77 / Chapter 4.4 --- SERPING1 Gene Polymorphisms in Uveitis --- p.94 / Chapter 4.4.1 --- Introduction --- p.94 / Chapter 4.4.2 --- Study subjects --- p.94 / Chapter 4.4.3 --- SNP selection and genotyping --- p.95 / Chapter 4.4.4 --- Statistical analysis --- p.95 / Chapter 4.4.5 --- Association of SERPING1 polymorphisms with AU --- p.95 / Chapter 4.4.5.1 --- Association between SNPs and AU --- p.95 / Chapter 4.4.5.2 --- Association between SNPs and AU stratified by gender --- p.96 / Chapter 4.4.5.3 --- Association between SNPs and AU stratified by HLA-B27 status --- p.96 / Chapter 4.4.5.4 --- Association between SNPs and AU stratified by clinical features --- p.96 / Chapter 4.4.6 --- Association of SERPING1 polymorphisms with NIPU --- p.96 / Chapter 4.4.6.1 --- Association between SNPs and NIPU --- p.97 / Chapter 4.4.6.2 --- Association between SNPs and NIPU stratified by subtypes --- p.97 / Chapter 4.4.6.3 --- Association between SNPs and NIPU stratified by gender --- p.97 / Chapter 4.4.7 --- Discussion --- p.98 / Chapter 4.5 --- C3 Gene Polymorphisms in Uveitis --- p.109 / Chapter 4.5.1 --- Introduction --- p.109 / Chapter 4.5.2 --- Study subjects --- p.109 / Chapter 4.5.3 --- SNP selection and genotyping --- p.110 / Chapter 4.5.4 --- Statistical analysis --- p.110 / Chapter 4.5.5 --- Association of C3 polymorphisms with AU --- p.110 / Chapter 4.5.5.1 --- Association between SNPs and AU --- p.110 / Chapter 4.5.5.2 --- Association between SNPs and AU stratified by gender --- p.111 / Chapter 4.5.5.3 --- Association between SNPs and AU stratified by HLA-B27 status --- p.111 / Chapter 4.5.5.4 --- Association between SNPs and AU stratified by clinical features --- p.111 / Chapter 4.5.6 --- Association of C3 polymorphisms with NIPU --- p.111 / Chapter 4.5.6.1 --- Association between SNPs and NIPU --- p.111 / Chapter 4.5.6.2 --- Association between SNPs and NIPU stratified by subtypes and gender --- p.112 / Chapter 4.5.7 --- Discussion --- p.112 / Chapter 4.6 --- C5 Gene Polymorphisms in Uveitis --- p.126 / Chapter 4.6.1 --- Introduction --- p.126 / Chapter 4.6.2 --- Study subjects --- p.126 / Chapter 4.6.3 --- SNP selection and genotyping --- p.127 / Chapter 4.6.4 --- Statistical analysis --- p.127 / Chapter 4.6.5 --- Association of C5 polymorphisms with AU --- p.127 / Chapter 4.6.5.1 --- Association between SNPs and AU --- p.127 / Chapter 4.6.5.2 --- Association between SNPs and AU stratified by gender --- p.128 / Chapter 4.6.5.3 --- Association between SNPs and AU stratified by HLA-B27 status and clinical features --- p.128 / Chapter 4.6.6 --- Association of C5 polymorphisms with NIPU --- p.128 / Chapter 4.6.6.1 --- Association between SNPs and NIPU --- p.128 / Chapter 4.6.6.2 --- Association between SNPs and NIPU stratified by subtypes --- p.129 / Chapter 4.6.6.3 --- Association between SNPs and NIPU stratified by gender --- p.129 / Chapter 4.6.7 --- Discussion --- p.129 / Chapter Chapter 5 --- Conclusions and Future Perspectives --- p.143 / Chapter 5.1 --- General Conclusion --- p.143 / Chapter 5.2 --- Future Research in Uveitis Molecular Genetics --- p.144 / REFERENCES --- p.148

Orientador: Gisele Fabrino Machado / Resumo: A leishmaniose visceral (LV) é uma antropozoonose sistêmica de evolução crônica, causada pela Leishmania infantum, de distribuição mundial, acometendo cães e humanos no ambiente urbano. Nos cães, são observados sinais clínicos frequentes tais como emagrecimento e linfoadenomegalia; e existem sinais clínicos menos estudados como as alterações inflamatórias no globo ocular. A hipótese deste estudo é que a ativação de MMPs pode estar envolvida na alteração da permeabilidade das barreiras oculares. Para verificar isto a presença e/ou ativação das metaloproteinases (MMP) 2 e 9, foram quantificadas por meio de zimografia do humor aquoso de 28 cães com LVC e 4 cães do grupo controle. A presença de Pro-MMP-2 foi detectada no humor aquoso de 27 animais do grupo infectado (27/28 cães) e também no grupo controle, sem diferir estatisticamente. A MMP-2 foi detectada no humor aquoso de um animal infectado. Já Pro-MMP-9 (10/28) e/ou sua forma ativa, (11/28) foram observadas em animais infectados e não no grupo controle. Para verificar se a presença das MMPs ativas poderia interferir com a integridade das barreiras oculares em cães com LVC, foi quantificada a presença de proteínas totais no soro e no humor aquoso destes cães. A quantificação de proteínas totais, albumina e globulinas no soro foram semelhantes aos valores citados na literatura no soro de animais com LV. No humor aquoso os valores individuais de proteína total, determinados pelo método Microprot apresentaram variação individua... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: Visceral leishmaniasis (VL) is a systemic anthropozoonosis of chronic evolution, caused by Leishmania infantum, worldwide, affecting dogs and humans in the urban environment. In dogs, frequent clinical signs such as weight loss and lymphadenomegaly are observed; and there are less studied clinical signs such as inflammatory changes in the eyeball. The hypothesis of this study is that the activation of MMPs may be involved in altering the permeability of eye barriers. To verify this the presence and / or activation of metalloproteinases (MMP) 2 and 9 were quantified by aqueous humor zymography of 28 dogs with CVL and 4 dogs of the control group. The presence of Pro-MMP-2 was detected in the aqueous humor of 27 animals of the infected group (27/28 dogs) and also in the control group, without statistically differing. MMP-2 was detected in the aqueous humor of an infected animal. Pro-MMP-9 (10/28) and / or its active form (11/28) were observed in infected animals and not in the control group. To verify whether the presence of active MMPs could interfere with the integrity of eye barriers in dogs with CVL, the presence of total proteins in serum and aqueous humor of these dogs was quantified. The quantification of serum total proteins, albumin and globulins were similar to those reported in the literature of serum from animals with VL. In aqueous humor the individual values of total protein determined by the Microprot method showed very large individual variation in both groups, a... (Complete abstract click electronic access below) / Mestre

No description available.

The primary aim of this research is to test the therapeutic potential of certain new generation corticosteroid drugs in order to develop safe and effective treatment for eye diseases that result in oedema, or swelling. The rising incidence of diabetes and the ageing population of developed countries mean that the prevalence of uveitis, diabetic retinopathy and age related macular degeneration will rise. Often, oedema is one of the reasons for vision loss. Corticosteroids are often used to reduce inflammation. Inflammation is one of several sources of oedema. Glucocorticoids, a class of corticosteroids that have anti-inflammatory properties, are thus used to treat ocular oedema. There is an unmet need to support clinical experience of the efficacy of steroids for ocular inflammation and oedema with more substantial scientific evidence. None of the drugs under investigation, with the exceptions of dexamethasone and triamcinolone, have been used for any ocular therapeutic purpose before. This thesis investigates “repurposing” fludrocortisone to the ophthalmic area. 11-Desoxycorticosterone (11D) and Deoxycorticosterone (DCS), other potentially valuable mineralocorticoids, remain completely untested. Lastly, Kenacort ®, or triamcinolone acetonide (TCA), is only used off-label by ophthalmologists. Methods: In the first study, corticosteroids, and especially mineralocorticoids, were investigated for their treatment efficacy in experimental uveitis, or intraocular inflammation (using a model known as endotoxin induced uveitis). In the second study, endothelial cells from choroidal blood vessels in the back of the eye were used in vitro to study whether corticosteroids reduce paracellular (between cells) permeability. Lastly, since endophthalmitis due to frequent injections is a side effect of corticosteroid use, the pharmacokinetics of different size formulations of corticosteroids were studied in an effort to find a formula that would have a prolonged dwell time within the eye.

published_or_final_version / Public Health / Master / Master of Public Health

published_or_final_version / Public Health / Master / Master of Public Health

An Enhanced Polarization-Sensitive Swept Source Optical Coherence Tomography (EPS-SS-OCT) instrument for high sensitivity cross-sectional imaging of Retinal Nerve Fiber Layer (RNFL) has been designed, constructed, and verified. The instrument is capable of measuring the thickness and birefringence of the RNFL. Birefringence change of the RNFL could serve as an early indicator of glaucoma. The associated image processing methods for completely automated, time efficient algorithm to segment the RNFL in images of the human retina recorded by the EPS-SS-OCT. Detected RNFL boundaries are used to compute peripapillary thickness maps. Numerical algorithms to compute the birefringence of the detected RNFL layer are presented along with the associated phase retardation and birefringence peripapillary maps. Glaucoma affects the vitality of retinal ganglion cell axons in the retinal nerve fiber layer (RNFL) and may be clinically detected through a change in RNFL birefringence. Comprehensive peripapillary maps of healthy and glaucoma suspect human RNFL birefringence were constructed using EPS-SS-OCT. Presence of macrophages is a hallmark of several retinal diseases such as drusen and age related macular degeneration. Application of photothermal Optical Coherence Tomography (OCT) to detect macrophages in ex vivo arteries which have engulfed nanoclusters of gold coated iron oxide (nanorose) is reported. Nanorose engulfed by macrophages in arteries absorb incident laser (800nm) energy and cause optical pathlength (OP) variation which is measured using photothermal OCT. OP variation in polydimethyl siloxane tissue phantoms containing varying concentrations of nanorose match values predicted from nanoparticle and material properties. Measurement of OP variation in arteries in response to laser excitation provides an estimate of nanorose concentration in arteries 2.5x109 particles/ml. OP variation in nanoparticle containing artery sections and tissue phantoms taking up nanorose has a different magnitude and profile from that observed in control aorta and phantoms without macrophages and is consistent with macrophage presence as identified with RAM-11 histology staining. Our results suggest that tissue regions with macrophages taking up nanorose can be detected using photothermal OCT. / text

Ištyrėme dviems šimtams gyvūnų ašarų sekrecijos lygį 400 akių. Tiriamieji objektai – kliniškai sveiki įvairios rūšies, amžiaus, lyties, veislės ir įvairiomis akių ligomis sergantys gyvūnai (triušiai, kiaulės, karvės, arkliai, šunys, katės). Analizavome gyvūno rūšies, amžiaus, veislės, lyties, paros ir metų laikotarpių, bei akių ligų įtaką kiekybiniams ašarų sekrecijos rodikliams, taip pat narkozės įtaką ašarų sekrecijai bendrosios anestezijos protokole naudojant skirtingus bendruosius anestetikus. Darbo tikslas. Nustatyti kai kurių naminių gyvūnų kiekybinius ašarų liaukos sekrecijos rodiklius ir įvertinti kai kurių veiksnių įtaką jiems. Visiems gyvūnams atlikome bendrąjį klinikinį tyrimą ir išmatavome ašarų kiekį akyje Širmerio testu, rodančiu bendrąjį (bazinį ir refleksinį kartu) ašarų sekrecijos lygį, ašarų liaukų sekrecinį pajėgumą. Rezultatai ir išvados. Analizuodami tyrimo rezultatus nustatėme, kad gyvūno rūšis turi įtakos ašarų sekrecijos kiekybiniams parametrams: daugiausia ašarų sekretuoja arklių akių ašarų liaukos – 25,45 ± 1,04 mm/min. Nustatėme, kad gyvūnų lytis daro įtaką ašarų liaukų sekretuojamam ašarų kiekiui ir ji priklauso nuo gyvūno rūšies. Tirtų gyvūnų, išskyrus kates, ašarų sekrecija yra aktyvesnė dieną. Tirtų gyvūnų, išskyrus arklius, ašarų sekrecija yra aktyvesnė vasarą. Gyvūnų ašarų sekrecijos pajėgumas ženkliai sumažėja sergant akių ligomis: konjunktyvitu ir uveitu, o sergant katarakta ašarų sekrecijos pokyčiai yra nežymūs. Narkotizuotų kiaulių akyse... [toliau žr. visą tekstą] / We examined two hundred animal tear secretion rate in 400 eyes. Subjects – various clinically healthy animal species, age, sex, breed, and animals with various eye diseases (rabbits, pigs, cows, horses, dogs, cats). We also analyzed animal specie, age, gender, time of a day, seasons influence as well as the influence to the tears secretion using different general anesthetics. Objective. Set some pet quantitative lacrimal gland secretion rates and assess the factors which influence them. We have done a general clinical examination and measurements of the amount of tears in the eyes for all animals using schirmer test, which shows a general (basic and reflex together) tear secretion level of the lacrimal secretion capacity. Results and conclusions. Analyzing the results we found that animal species affects the secretion of tears quantitative parameters. Most tears secrets horse eye lacrimal glands – 25,45 ± 1,04 mm / min. We found that animals sex affects the tear glands secretion quantity and it depends on the animal species. Of all analyzed animals except cats tear secretion is more active in day time. Of all analyzed animals except horses, tear secretion is more active in the summer. Animal tear secretion capacity is significantly reduced in patients with eye diseases: conjunctivitis and uveitis but patients with cataract tear secretion changes are minor. In narcotized pigs decreased excretion of tears in the eyes also anesthesia with double cocktail of thiopental –... [to full text]